Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr 3-octreotate in a small cell lung cancer animal model

Cancer Biotherapy and Radiopharmaceuticals

Volumn 20, Issue 2, 2005, Pages 231-236

  Schmitt, Anneli ^a   Bernhardt, Peter ^a   Nilsson, Ola ^a   Ahlman, Håkan ^a   Kölby, Lars ^a   Forssell Aronsson, Eva ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biodistribution; Nude mice; Radiolabeled somatostatin analogs; Small cell lung cancer

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID TYROSINE OCTREOTATE LU 177; DEPREOTIDE TC 99M; PENTETIC ACID OCTREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; (177LUTETIUM DOTA(O)TYR3)OCTREOTATE; (177LUTETIUM-DOTA(O)TYR3)OCTREOTATE; 111IN OCTREOTIDE, DTPA(0); 111IN-OCTREOTIDE, DTPA(0)-; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; ORGANOMETALLIC COMPOUND; PENTETIC ACID; SOMATOSTATIN; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE MARROW; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; HEART; LIVER; LUNG; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND; SPLEEN; TUMOR SCINTISCANNING; XENOGRAFT; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; DISEASE MODEL; EXPERIMENTAL NEOPLASM; HUMAN; LUNG TUMOR; NUDE MOUSE; PATHOLOGY; SMALL CELL CARCINOMA; TIME; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; INDIUM RADIOISOTOPES; LIVER; LUNG; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PENTETIC ACID; RADIOPHARMACEUTICALS; SOMATOSTATIN; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 18844396135     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2005.20.231     Document Type: Conference Paper

References (19)

1. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003;24:389.
2. 3]octreotate. Eur J Nucl Med Mol Imaging 2003;30:417.
3. 3] octreotate in a rat liver micrometastases model. Int J Cancer 2003;104:376.
4. 3-octreotate in an animal model. J Nucl Med 2004;45:1542.
5. Reisinger I, Bohuslavitzki, KH, Brenner W, et al. Somatostatin receptor scintigraphy in small cell lung cancer: Results of a multicenter study. J Nucl Med 1998;39:224.
6. Berenger N, Moretti JL, Boaziz C, et al. Somatostatin receptor imaging in small cell lung cancer. Eur J Cancer 1996;32A:1429.
7. Hochstenbag MM, Heidendal GA, Wouters EF, et al. In-111 octreotide imaging in staging of small cell lung cancer. Clin Nucl Med 1997;22:811.
8. 99m)Tc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000;117:1232.
9. Grewal RK, Dadparvar S, Yu JQ, et al. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules. Cancer J 2002;8:400.
10. EMEA CPMP/2065/00: European Medicines Agency, 2000.
11. Reubi JC, Schar JC, Wasar B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27:273.
12. 3]octreotate in male nude mice with human small cell lung cancer. Cancer Biother Radiopharm 2003;18:593.
13. 111In- pentetreotide scintigraphy. J Nucl Med 2002;43:889.
14. ICRP Publication 80: International Commission on Radiological Protection, 1998.
15. 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: Influence of amount injected and route of administration. Nucl Med Biol 2003;30:253.
16. Taylor JE, Theveniau MA, Bachirzadeh R, et al. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity. Peptides 1994;15:1229.
17. De Jong M, Valkema R, Jamar F, et al. Somatostatin receptor-targeted radionuclide therapy of tumors: Pre-clinical and clinical findings. Semin Nucl Med 2002;32:133.
18. Forssell-Aronsson E, Fjälling M, Nilsson O, et al. Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. J Nucl Med 1995;36:7.
19. 3]octreotate prior to administration reduces rat skeleton uptake of radioactivity. Eur J Nucl Med Mol Imaging 2003;30:312.